Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2024 03:30 ET | Source: Allied Analytics LLP

Atorvastatin Calcium Market to Reach $487.8 Million, Globally, by 2033 at 5% CAGR: Allied Market Research

Wilmington, Delaware, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Atorvastatin Calcium Market by Form (Tablets and Others), Application...
June 28, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Hyperlipidemia Market to Register Immense Growth, Predicts DelveInsight | Key Companies in the Market - Amgen, Eli Lilly and Company, AstraZeneca, Arrowhead, Pfizer, Regeneron, Sanofi, AbbVie, GlaxoSmithKline

New York, USA, June 28, 2023 (GLOBE NEWSWIRE) -- Hyperlipidemia Market to Register Immense Growth, Predicts DelveInsight | Key Companies in the Market - Amgen, Eli Lilly and Company, AstraZeneca,...
March 27, 2023 13:30 ET | Source: Transparency Market Research

Antihyperlipidemic Drugs Market to Hit USD 20.1 Bn by 2031 | Transparency Market Research

Wilmington, Delaware, United States, March 27, 2023 (GLOBE NEWSWIRE) -- According to the exhaustive antihyperlipidemic drugs market report by TMR, the global industry was valued USD 12.0 Bn in 2022...
October 18, 2022 08:40 ET | Source: The Insight Partners

$55+ Billion Stroke Management Market Size to Rise at a Stellar CAGR of 7.5% During (2022-2028) - COVID-19 Impact and Global Analysis by The Insight Partners

New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Stroke Management Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...
November 12, 2018 12:30 ET | Source: Shifa Biomedical

Shifa Biomedical Corporation Presents Preclinical Data on P-21, a Novel Orally Active PSCK9 Antagonist, at the American Heart Association (AHA) Meeting, Scientific Sessions 2018

CHICAGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Shifa Biomedical Corporation (Shifa), a drug discovery biopharmaceutical company focused on developing novel agents to treat cardiovascular disease and...
March 17, 2016 07:00 ET | Source: Admera Health, LLC

Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk

SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...